Chemring Group (LSE:CHG) plc’s upcoming full-year results come on the back of a few big-tiket wins for the aerospace and defence mid-cap.
In November, Chemring announced two munitions contracts for the German and US military worth £278 million.
Earlier in the year, Chemring’s Norwegian subsidiary signed a 15-year partnering agreement with Northrop Grumman to supply HMX material used in its missile programmes.
Full-year operating profit is expected to be in line with market expectations of around £70.9 million.
Chemring shares are up 8.5% year to date.